Skip to content

Efficacy of Split-dose of Oral MMS for Bowel Preparation in Elderly Patients

Efficacy of Split-dose of Oral Magnesium Sulfate Solution for Bowel Preparation in Elderly Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04948567
Enrollment
1174
Registered
2021-07-02
Start date
2017-01-30
Completion date
2019-12-01
Last updated
2021-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation, Colonic Adenoma

Keywords

bowel preparation, Oral magnesium sulfate solution, polyethylene glycol solution

Brief summary

Adequate bowel preparation is critical for successful colonoscopy and a large volume of PEG was required for bowel preparation in patients undergoing colonoscopy. The investigators conducted a a prospective, randomized, controlled study to compare low dose of oral magnesium sulfate solution with high dose PEG. The investigators found that patients who took low dose of oral magnesium sulfate solution had similar bowel preparation quality to patients who took PEG,but accompanied with fewer adverse events and better tolerance.

Interventions

OTHERsplit-dose of Magnesium Sulfate solution

purgative for bowel preparation

OTHERsplit-dose of PEG

purgative for bowel preparation

Sponsors

Air Force Military Medical University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
60 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* patients who underwent colonoscopy

Exclusion criteria

* known or suspected bowel stricture or obstruction; * history of colorectal surgery; * significant gastroparesis or gastric outlet obstruction; * toxic colitis or megacolon; * severe acute inflammatory bowel disease; * active gastrointestinal bleeding; * suspected or confirmed chronic renal insufficiency and heart illness; * disturbance of electrolytes ; * unable to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
The rate of patients with adequate bowel preparation1 yearDefined by each segmental BBPS≥2

Secondary

MeasureTime frameDescription
The rate of adenoma detection1 yearThe proportion of participants with at least one adenoma in each group
the numbers of patients with adverse events1 yeareg. Vomiting, nausea, abdominal pain
The cecal intubation rate1 yearThe rate of colonoscopy reaching the cecum
The time of Cecal intubationduring procedurethe time between the intubation and visualization of any of the following anatomic landmarks: ileocecal valve, appendiceal orifice, or terminal ileum
the time during Withdrawal phageduring procedurethe inspection time from cecum to rectum

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026